StockNews.com started coverage on shares of NovaBay Pharmaceuticals (NYSEAMERICAN:NBY – Get Rating) in a research note released on Tuesday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. NovaBay Pharmaceuticals Stock Performance NYSEAMERICAN NBY opened at $0.68 on Tuesday. The company has a market capitalization of $1.27 million, a price-to-earnings ratio of […]
StockNews.com assumed coverage on shares of NovaBay Pharmaceuticals (NYSEAMERICAN:NBY – Get Rating) in a research report sent to investors on Tuesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. NovaBay Pharmaceuticals Price Performance Shares of NBY opened at $0.68 on Tuesday. The firm has a market cap of $1.27 million, a […]
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY – Get Rating) announced its quarterly earnings data on Thursday. The biopharmaceutical company reported ($0.85) earnings per share for the quarter, reports. NovaBay Pharmaceuticals had a negative return on equity of 18.62% and a negative net margin of 21.09%. The firm had revenue of $3.12 million during the quarter. NovaBay Pharmaceuticals Stock […]
NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY – Get Rating) passed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $1.73 and traded as low as $0.95. NovaBay Pharmaceuticals shares last traded at $0.98, with a volume of 27,074 shares. Analysts Set New Price Targets Separately, StockNews.com […]
NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY – Get Rating) was the recipient of a large growth in short interest in May. As of May 31st, there was short interest totalling 1,290,000 shares, a growth of 41.6% from the May 15th total of 910,800 shares. Based on an average daily trading volume, of 590,700 shares, the short-interest ratio […]